SINGAPORE, May 19 (Reuters) - London copper climbed to a two-month high on Tuesday, as positive data from an early-stage trial for a coronavirus vaccine and moves by many countries to ease restrictions lifted investor optimism about a pickup in economic activities.
Moderna Inc’s experimental COVID-19 vaccine, the first to be tested in the United States, produced protective antibodies in a small group of healthy volunteers, very early data released by the biotech company showed.
Three-month copper on the London Metal Exchange (LME) rose as much as 1.1% to $5,377.50 a tonne, its highest since March 16.
The most-traded copper contract on the Shanghai Futures Exchange advanced 2% to 43,770 yuan ($6,157.33) a tonne.
* OTHER PRICES: LME aluminium rose 0.2% to $1,499.50 a tonne, while nickel advanced 0.3% to $12,290 a tonne. In Shanghai, aluminium hit a 2-1/2-month high of 12,920 yuan a tonne, while nickel jumped 2.9% to 101,930 yuan a tonne.
* EU: France and Germany proposed a 500-billion-euro ($545.65 billion) Recovery Fund for European Union regions and sectors hit hardest by the pandemic.
* For the top stories in metals and other news, click or
* Asian shares were set to rise after data from Moderna lifted hopes for a near-term economic recovery, sending global equity markets and oil prices surging.
0600 UK Claimant Count Unem Chng April
0600 UK ILO Unemployment Rate March
0600 UK Employment Change March
0900 Germany ZEW Economic Sentiment May
0900 Germany ZEW Current Conditions May
1230 US Building Permits: Number April
1230 US Housing Starts Number April
Three month LME copper
Most active ShFE copper
Three month LME aluminium
Most active ShFE aluminium
Three month LME zinc
Most active ShFE zinc
Three month LME lead
Most active ShFE lead
Three month LME nickel
Most active ShFE nickel
Three month LME tin
Most active ShFE tin
ARBS ($1 = 7.1086 yuan) ($1 = 0.9163 euros) (Reporting by Mai Nguyen; Editing by Subhranshu Sahu)